PMP22 Mutation Screening with Next Generation Sequencing and Multiplex Ligation-dependent Probe Amplification Approach

Huan XU,Xiang-jun CHEN,Ling-yun GONG,Dong-qing ZHU,Ting QIAN,Jun-lan LV,Yao YANG,Wen-chuan ZHANG
2015-01-01
Abstract:Aim To ifnd out the application and effectiveness of high-throughput sequencing method, a next generation sequencing (NGS) method in screening the peripheral myelin protein 22 (PMP22) gene mutation. Methods The peripheral blood collected from ifve enrolled patients suspected of Charcot-Marie-Tooth disease (CMT) type 1 were detected by high-throughput sequencing of PMP22. Results The results of 1 case of PMP22 deletion mutation and 3 cases of PMP22 duplication mutation by NGS, were the same results as with multiplex ligation-dependent probe ampliifcation (MLPA). The result of 1 case of PMP22 point mutation was accordance with the result by Sanger method. Conclusion NGS method can be not only applied to the exact analysis for deletion or duplication mutation of PMP22, but also applied to PMP22 point mutation detection, which is convenient and helpful for early confirmation of CMT1A/hereditary neuropathy with liability to pressure palsies (HNPP) and prognosis evaluation, prenatal diagnosis. And NGS will become a one-stand genetic screen method.
What problem does this paper attempt to address?